abstract |
A method is described for treating or preventing organ injury, delayed type hypersensitivity, graft-versus-host disease or allograft rejection, for example in the lung, kidney, heart, liver in a subject by administering to the subject an effective amount of a CCR4 inhibitor or antagonist. |